share_log

Goldman Sachs Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $1.1

Moomoo 24/7 ·  Jan 22 07:43

Goldman Sachs analyst Matthew Sykes maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $1.25 to $1.1.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment